CSF2 and acute myeloid leukemia: Furthermore, using CSF1R inhibitors and granulocyte-macrophage colony-stimulating factor (GM-CSF), we succeeded in reprogramming protumoral AML-MΦs and in reversing drug-resistance induced by myeloblast cross-talk with MΦs.